QCM
CYTK icon

Quantinno Capital Management’s Cytokinetics CYTK Stock Holding History

Quantinno Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.28M Sell
50,259
-2,339
-4% -$168K 0.01% 1380
2026
Q1 		$3.47M Buy
52,598
+2,161
+4% +$137K 0.01% 1309
2025
Q4 		$3.2M Buy
50,437
+22,000
+77% +$1.37M 0.01% 1192
2025
Q3 		$1.56M Buy
+28,437
New +$1.17M ﹤0.01% 1306

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantinno Capital Management's CYTK Position: Q2 2026 in Review

Quantinno Capital Management reduced its Cytokinetics (CYTK) stake by 4.4% in Q2 2026, selling an estimated $168K and leaving 50,259 shares worth $4.28M. The position accounts for 0.01% of the portfolio, ranked #1380.

Quantinno Capital Management first reported a position in CYTK in Q3 2025 and has held it in 4 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Quantinno Capital Management held 50,259 shares of Cytokinetics worth $4.28M as of Q2 2026.
  • Quantinno Capital Management sold 2,339 Cytokinetics shares in Q2 2026, an estimated $168K.
  • Cytokinetics made up 0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1380 holding.
  • Quantinno Capital Management first reported a position in Cytokinetics in Q3 2025 and has held it in 4 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.